Cohance Lifesciences Limited — Others, 27-12-2024: Trading Window

Suven Pharmaceuticals Limited has announced a board meeting on February 12, 2025, to consider and approve the financial results for the quarter and nine-months ending December 31, 2024. The trading window will be closed from January 1 to February 14, 2025, which may impact liquidity for investors during this period. This development signals management's focus on financial transparency and structured governance, potentially influencing investor sentiment positively, pending the financial performance review. Investors may view this as an opportunity to assess the company’s growth trajectory in the competitive pharmaceutical landscape.